AVITA Medical (ASX: AVH) is set to enhance patient care with its new FDA-cleared collagen-based dermal matrix in collaboration with Regenity Biosciences. This innovative technology will catalyse healing for chronic wounds and severe skin injuries, offering patients quality of care through faster recovery and better skin restoration. “This strategic collaboration significantly strengthens our portfolio and
Read More
4,440 US hospitals and health systems will soon have access to Avita Medical’s (ASX: AVH) proprietary RECELL System thanks to a purchasing agreement signed with Premier, a leading healthcare improvement company in the US. Premier’s mission is to enable optimal patient care at reasonable cost within their alliance of 4,400 US hospitals and 225,000 other
Read More
The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter with the Company reporting strong revenue. The Company was founded to develop and commercialise the RECELL “spray-on skin” product, invented in Perth by Professor Fiona Wood. Professor Wood is a world renowned surgeon and researcher
Read More